Ask AI
ProCE Banner Activity

Key HIV Studies From CROI 2024 Influencing Clinical Practice

Conference Coverage
Podcast Episodes

Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the most clinically relevant new data presented at CROI 2024, including long-acting ART, comorbidities and coinfections, and what’s on the horizon in HIV treatment.

Released: March 29, 2024

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Disclosure

Primary Author

Joseph J. Eron, Jr., MD

Herman and Louise Smith Distinguished Professor of Medicine
Chief, Division of Infectious Disease
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology, Gillings School of Global Public Health
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina

Joseph J. Eron Jr., MD: consultant/advisor/speaker: AbbVie, Gilead, Merck, ViiV; researcher: Gilead.

Monica Gandhi, MD, MPH

Professor of Medicine and Associate Chief
Division of HIV, Infectious Diseases, and Global Medicine
Director, UCSF Center for AIDS Research (CFAR)
Director of HIV Special Program
"Ward 86" HIV Clinic
San Francisco General Hospital
San Francisco, California

Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.